132 related articles for article (PubMed ID: 18064463)
1. Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer.
Lee I; Shogen K
Cancer Chemother Pharmacol; 2008 Jul; 62(2):337-46. PubMed ID: 18064463
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic mechanisms of ranpirnase-induced enhancement of radiation response on A549 human lung cancer.
Lee I; Kim DH; Sunar U; Magnitsky S; Shogen K
In Vivo; 2007; 21(5):721-8. PubMed ID: 18019404
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.
Lee I; Kalota A; Gewirtz AM; Shogen K
Anticancer Res; 2007; 27(1A):299-307. PubMed ID: 17352247
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms of improved radiation response by cytotoxic RNase, Onconase, on A549 human lung cancer xenografts of nude mice.
Kim DH; Kim EJ; Kalota A; Gewirtz AM; Glickson J; Shogen K; Lee I
Adv Exp Med Biol; 2007; 599():53-9. PubMed ID: 17727247
[TBL] [Abstract][Full Text] [Related]
5. Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.
Shen R; Li J; Ye D; Wang Q; Fei J
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):894-901. PubMed ID: 27590062
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of activation-induced apoptosis of lymphocytes by the cytotoxic ribonuclease onconase (Ranpirnase).
Halicka DH; Pozarowski P; Ita M; Ardelt WJ; Mikulski SM; Shogen K; Darzynkiewicz Z
Int J Oncol; 2002 Dec; 21(6):1245-50. PubMed ID: 12429974
[TBL] [Abstract][Full Text] [Related]
7. Tumoricidal effects of onconase on various tumors.
Lee I; Lee YH; Mikulski SM; Lee J; Covone K; Shogen K
J Surg Oncol; 2000 Mar; 73(3):164-71. PubMed ID: 10738271
[TBL] [Abstract][Full Text] [Related]
8. Ranpirnase (Onconase), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy.
Lee I
Expert Opin Biol Ther; 2008 Jun; 8(6):813-27. PubMed ID: 18476793
[TBL] [Abstract][Full Text] [Related]
9. [Onconase: a ribonuclease with antitumor activity].
Zwolińska M; Smolewski P
Postepy Hig Med Dosw (Online); 2010 Feb; 64():58-66. PubMed ID: 20173221
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of acriflavine in lung adenocarcinoma cell line A549.
Lee CJ; Yue CH; Lin YJ; Lin YY; Kao SH; Liu JY; Chen YH
Anticancer Res; 2014 Nov; 34(11):6467-72. PubMed ID: 25368247
[TBL] [Abstract][Full Text] [Related]
11. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
[TBL] [Abstract][Full Text] [Related]
13. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
14. Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models.
Baker AF; Hanke NT; Sands BJ; Carbajal L; Anderl JL; Garland LL
J Exp Clin Cancer Res; 2014 Dec; 33(1):111. PubMed ID: 25612802
[TBL] [Abstract][Full Text] [Related]
15. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
[TBL] [Abstract][Full Text] [Related]
16. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
17. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of 188Re-MAG3-depreotide on non-small cell lung cancer in vivo and in vitro.
Yu F; Lv M; Cai H; Li D; Yuan X; Lv Z
Int J Clin Exp Pathol; 2013; 6(3):421-30. PubMed ID: 23411669
[TBL] [Abstract][Full Text] [Related]
19. A flavonoid isolated from Streptomyces sp. (ERINLG-4) induces apoptosis in human lung cancer A549 cells through p53 and cytochrome c release caspase dependant pathway.
Balachandran C; Sangeetha B; Duraipandiyan V; Raj MK; Ignacimuthu S; Al-Dhabi NA; Balakrishna K; Parthasarathy K; Arulmozhi NM; Arasu MV
Chem Biol Interact; 2014 Dec; 224():24-35. PubMed ID: 25289772
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
Xie CY; Xu YP; Jin W; Lou LG
Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
